Zilin Li

1.2k total citations
45 papers, 858 citations indexed

About

Zilin Li is a scholar working on Physiology, Cancer Research and Molecular Biology. According to data from OpenAlex, Zilin Li has authored 45 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Zilin Li's work include Traditional Chinese Medicine Analysis (4 papers), Bone and Joint Diseases (4 papers) and Air Quality and Health Impacts (3 papers). Zilin Li is often cited by papers focused on Traditional Chinese Medicine Analysis (4 papers), Bone and Joint Diseases (4 papers) and Air Quality and Health Impacts (3 papers). Zilin Li collaborates with scholars based in China, United States and Taiwan. Zilin Li's co-authors include Bo Xi, Min Zhao, Chuanwei Ma, Yajun Liang, Han Wu, Shu Yuan, Pascal Bovet, Sicong Jiang, Jing Hu and Emerald G. Heiland and has published in prestigious journals such as PLoS ONE, Biomaterials and Chemical Engineering Journal.

In The Last Decade

Zilin Li

42 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zilin Li China 15 209 175 108 90 80 45 858
Yi‐Ching Lin Taiwan 19 199 1.0× 116 0.7× 40 0.4× 124 1.4× 51 0.6× 67 1.0k
Fangfang Fan China 23 331 1.6× 138 0.8× 71 0.7× 167 1.9× 117 1.5× 151 2.0k
Hao Zheng China 22 433 2.1× 76 0.4× 157 1.5× 124 1.4× 28 0.3× 68 1.4k
Dillip Kumar Parida India 8 158 0.8× 254 1.5× 24 0.2× 97 1.1× 103 1.3× 35 938
Qian Wu China 20 353 1.7× 100 0.6× 106 1.0× 78 0.9× 75 0.9× 74 1.2k
Xinping Luo China 23 346 1.7× 194 1.1× 90 0.8× 100 1.1× 188 2.4× 60 1.6k
Michael Daniel United States 12 327 1.6× 267 1.5× 58 0.5× 66 0.7× 63 0.8× 19 947
Nahid Karamzad Iran 17 118 0.6× 183 1.0× 64 0.6× 53 0.6× 181 2.3× 41 1.2k
Mohamed Elmahdy Egypt 16 484 2.3× 137 0.8× 65 0.6× 104 1.2× 58 0.7× 41 1.0k
Yuhan Chen China 18 274 1.3× 78 0.4× 53 0.5× 88 1.0× 113 1.4× 80 1.2k

Countries citing papers authored by Zilin Li

Since Specialization
Citations

This map shows the geographic impact of Zilin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zilin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zilin Li more than expected).

Fields of papers citing papers by Zilin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zilin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zilin Li. The network helps show where Zilin Li may publish in the future.

Co-authorship network of co-authors of Zilin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zilin Li. A scholar is included among the top collaborators of Zilin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zilin Li. Zilin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zilin, Chao Fang, Jing Yuan, et al.. (2025). Solid Self-Microemulsifying Drug Delivery System for Improved Oral Bioavailability of Relugolix: Preparation and Evaluation. International Journal of Nanomedicine. Volume 20. 1065–1082. 2 indexed citations
2.
Wang, Cong, Hui Xu, Jianjian Wang, et al.. (2025). Isocoumarins from Spegazzinia sp. MDCW-573 with Antibacterial and Proangiogenic Activities. Journal of Natural Products. 88(3). 757–767.
4.
Cheng, Guowang, Zhiwen Liu, Jiaxin Wu, et al.. (2024). Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment. Journal of Controlled Release. 377. 591–605. 6 indexed citations
7.
Wang, Ping, et al.. (2024). Associations of osteoarthritis with risk of future fracture events: prospective study in UK Biobank. International Journal of Surgery. 111(2). 1911–1918. 1 indexed citations
8.
Liu, Xiang, Feng Guo, Desheng Liang, et al.. (2023). Development and evaluation of finasteride niosomes targeting to hair follicles for the management of androgenic alopecia. Journal of Drug Delivery Science and Technology. 86. 104725–104725. 9 indexed citations
9.
Luca, Roberto De, Chi‐Hung Huang, Yu‐Chen S. H. Yang, et al.. (2022). Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition. Food and Chemical Toxicology. 161. 112850–112850. 10 indexed citations
10.
Cheng, Tsai-Mu, Haw‐Ming Huang, Zilin Li, et al.. (2022). Toxicologic Concerns with Current Medical Nanoparticles. International Journal of Molecular Sciences. 23(14). 7597–7597. 31 indexed citations
11.
Lin, Hung‐Yun, Yung‐Ning Yang, Dana R. Crawford, et al.. (2022). 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-Glucoside improves female ovarian aging. Frontiers in Cell and Developmental Biology. 10. 862045–862045. 8 indexed citations
12.
Ma, Jipeng, et al.. (2022). Improvement of Cardiovascular Function in Aging Females by the Prolonged Activation of G Protein-Coupled Estrogen Receptor. Journal of Cardiovascular Translational Research. 16(2). 371–381. 6 indexed citations
13.
Wang, Kuan, Yu‐Chen S. H. Yang, Haw‐Ming Huang, et al.. (2022). The power of heteronemin in cancers. Journal of Biomedical Science. 29(1). 41–41. 7 indexed citations
14.
Yang, Mengmeng, Zhen Li, Jianping Tao, et al.. (2021). Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells. Journal of Cancer Research and Clinical Oncology. 147(4). 1101–1113. 53 indexed citations
15.
Li, Zilin, et al.. (2021). Two-Year Change in Blood Pressure Status and Left Ventricular Mass Index in Chinese Children. Frontiers in Medicine. 8. 6 indexed citations
16.
Wang, Xiaowu, Jipeng Ma, Shuaishuai Zhang, et al.. (2021). G Protein–Coupled Estrogen Receptor 30 Reduces Transverse Aortic Constriction–Induced Myocardial Fibrosis in Aged Female Mice by Inhibiting the ERK1/2 -MMP-9 Signaling Pathway. Frontiers in Pharmacology. 12. 731609–731609. 14 indexed citations
17.
Li, Zilin, et al.. (2020). GAS6-AS2 Promotes Hepatocellular Carcinoma via miR-3619-5p/ARL2 Axis Under Insufficient Radiofrequency Ablation Condition. Cancer Biotherapy and Radiopharmaceuticals. 36(10). 879–887. 11 indexed citations
18.
Li, Zilin, et al.. (2020). Exploring the young demographic profile of COVID-19 cases in Hong Kong: Evidence from migration and travel history data. PLoS ONE. 15(6). e0235306–e0235306. 13 indexed citations
19.
Xu, Zihan, Zilin Li, Sumeng Gao, et al.. (2018). PM2.5 induced pulmonary fibrosis in vivo and in vitro. Ecotoxicology and Environmental Safety. 171. 112–121. 97 indexed citations
20.
Luo, Yin, Huan‐Qiu Li, Yang Zhou, et al.. (2010). Metronidazole–Deoxybenzoin Derivatives as Anti‐Helicobacter pylori Agents with Potent Inhibitory Activity against HPE‐Induced Interleukin‐8. ChemMedChem. 5(7). 1110–1116. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026